Aerocrine Sales Grow To Record Levels Again For 1st Quarter, NIOX VERO Launch In The US Off To A Strong Start

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News:

Aerocrine (STO:AEROB):

January – March 2015

· Net sales increased by 52% to SEK 53.2m (35.0)*. Adjusted for exchange rates, net sales increased by 31%.

- Clinical sales were SEK 38.9m, an increase of 32%.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC